MOH approves Pfizer BioNtech vaccine for pregnant and breast feeding women in T&T

MOH approves Pfizer BioNtech vaccine for pregnant and breast feeding women in T&T

The PfizerBioNTech or Pfizer vaccine has been approved, effective Wednesday August 25th, 2021, for administering to pregnant and breast feeding women in Trinidad and Tobago. The Ministry of health held a meeting with key stakeholders on August 17th, 2021 to discuss and approve the Pfizer vaccine to this cohort of citizens. The vaccine now approved for women who have passed their thirteenth week of pregnancy and beyond and also breastfeeding women.

This was announced by Director of women’s health at the MOH, Dr. Adesh Sirjusingh. The Ministry had previously approved the Sinopharm vaccine for pregnant and breastfeeding women in Trinidad and Tobago. Dr. Sirjusingh also updated the population that as of last week, 315 women had contracted covid-19 at varying stages of their pregnancy.

He also confirmed that only one case of mother to child transmission has taken place, and there has been one death of a covid positive women after she gave birth. The baby was reportedly doing well, and under the care and supervision of the specialists at the MOH. Dr. Sirjusingh also indicated that over 250 thousand pregnant women around the world have taken the covid-19 vaccine.

Both the Sinopharm and Pfizer vaccines have been approved by the WHO for pregnant and breastfeeding women.

COMMENTS

WORDPRESS: 0
DISQUS: 0